Dean, Tufts Clinical and Translational Science Institute, Exec Dir, Inst for Clin Res and Health Policy

Internal Medicine

Harry Selker is an expert in the field of Internal Medicine. He attended Warren Alpert Medical School of Brown University. Harry Selker is a published doctor as well. He has 71 publications published. The latest was: A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study(,,.) Harry Selker is registered with Medicare.

Publications

---

• A predictive model to identify patients with suspected acute coronary syndromes at high risk of cardiac arrest or in-hospital mortality: An IMMEDIATE Trial sub-study(,,.)
• Serum adiponectin levels in patients with acute coronary syndromes: Serial changes and relation to infarct size.
• The next frontier: Fostering innovation by improving health data access and utilization.
• Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trial.
• Quantity Over Quality: How the Rise in Quality Measures is Not Producing Quality Results.
• Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial.
• One-Year Outcomes of Out-of-Hospital Administration of Intravenous Glucose, Insulin, and Potassium (GIK) in Patients With Suspected Acute Coronary Syndromes (from the ...
• A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials.
• The National Physician Payment Commission Recommendation to Eliminate Fee-for-Service Payment: Balancing Risk, Benefit, and Efficiency in Bundling Payment for Care.
• The affordable care act as translational research.
• Satisfaction and Emergency Department Revisits in Patients With Possible Acute Coronary Syndrome.
• Gun violence is a health crisis: physicians' responsibilities.
• Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.
• Out-of-Hospital Administration of Intravenous Glucose-Insulin-Potassium in Patients With Suspected Acute Coronary Syndromes: The IMMEDIATE Randomized Controlled Trial.
• The importance of proposed changes in the "common rule" for -clinical and translational researchers.
• The central role of pharmacoepidemiology in comparative effectiveness research education: critical next steps.
• The need for academic leadership in full-spectrum translational research.
• Risk factor model to predict venous thromboembolism in hospitalized medical patients.
• Continuing regeneration of our spring meeting (now there are five organizations!).
• Random treatment assignment using mathematical equipoise for comparative effectiveness trials.
• Beyond translational research from T1 to T4: beyond “separate but equal” to integration (Ti).
• The citizen-scientist's role in advocacy for clinical and translational science.
• Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies.
• Clinical research and the public: if not them, who?
• Improving use of prehospital 12-lead ECG for early identification and treatment of acute coronary syndrome and ST-elevation myocardial infarction.
• Tufts CTSI: comparative effectiveness research as a conceptual framework for a focus on impact.
• The Stroke Practice Improvement Network: a quasiexperimental trial of a multifaceted intervention to improve quality.
• White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effe...
• Industry influence on comparative-effectiveness research funded through health care reform.
• Comparative effectiveness research: an approach to avoiding "overgeneralized medicine".
• Comparative effectiveness research: medical practice, payments, and politics: the need to retain standards of medical research.
• Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay?
• Glucose-insulin-potassium therapy in patients with STEMI.
• Do emergency department patients with possible acute coronary syndrome have better outcomes when admitted to cardiology versus other services?
• Benchmarks and determinants of adherence to stroke performance measures.
• Volume-outcome relationship for coronary artery bypass grafting in an era of decreasing volume.
• A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous c...
• A geospatial analysis of emergency transport and inter-hospital transfer in ST-segment elevation myocardial infarction.
• Does concordance with guideline triage recommendations affect clinical care of patients with possible acute coronary syndrome?
• Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction.
• The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke.
• Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window?
• The impact of unstable angina guidelines in the triage of emergency department patients with possible acute coronary syndrome.
• Triage and diagnosis of chest pain in rural hospitals: implementation of the ACI-TIPI in the High Plains Research Network.
• Emergency physicians' fear of malpractice in evaluating patients with possible acute cardiac ischemia.
• Acute coronary syndromes in the emergency department: diagnostic characteristics, tests, and challenges.
• Medical error prevention in ED triage for ACS: use of cardiac care decision support and quality improvement feedback.
• Evaluating the nondrug costs of formulary coverage restrictions.
• Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
• Quantitative instruments for predicting risk ... and benefit.
• Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.
• Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
• Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study.
• Acute resting myocardial perfusion imaging in patients with diabetes mellitus: results from the Emergency Room Assessment of Sestamibi for Evaluation of Chest Pain (ER...
• Implications of the mechanical (PCI) vs thrombolytic controversy for ST segment elevation myocardial infarction on the organization of emergency medical services: the ...
• In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
• The impact of electrocardiographic left ventricular hypertrophy and bundle branch block on the triage and outcome of ED patients with a suspected acute coronary syndro...
• Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions.
• Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?
• Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction.
• Diagnosis of acute cardiac ischemia.
• Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial.
• Is primary angioplasty for some as good as primary angioplasty for all?
• Atypical presentations among Medicare beneficiaries with unstable angina pectoris.
• An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator c...
• Does more "appropriateness" explain higher rates of cardiac procedures among patients hospitalized with coronary heart disease?
• Patient protection and risk selection: do primary care physicians encourage their patients to join or avoid capitated health plans according to the patient's health st...
• Electrocardiograph-based emergency department risk management tool based on the ACI-TIPI: potential impact on care and malpractice claims.
• Cardiovascular health awareness and the effect of an educational intervention on school-aged children in a rural district of India.
• A community consultation survey to evaluate support for and success of the IMMEDIATE trial.

Schools

---

• The Warren Alpert Medical School Of Brown University

• UCLACedars Sinai Mc

• Boston City Hospital

• Boston University Mc

• Rw Johnson Clin ScholarUCLA

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

Education

---

• UCLA Medical Center
• Boston University Medical Center
• Cedars-Sinai Medical Center
• Warren Alpert Medical School of Brown University

Hospital

---

• Tufts Medical Center

Drug Facts

---

NPI NUMBER		1235240995
NPPES Provider LastName		SELKER
NPPES Provider FirstName		HARRY
NPPES Provider ZIPCode		021111526
NPPES Provider State		MA
Specialty Description		Internal Medicine
Total Claim Count		393.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1235240995
Last Name Of The Provider	SELKER
First Name Of The Provider	HARRY
View All

Similar Doctors

---

	Dr. Edward C. Gilmore, MD This Doctor is OpenDoctor Recommended.
	Dr. Bushra W. Taha, MD This Doctor is OpenDoctor Recommended.
	Dr. Yiding Yu, MD
	Dr. Christine J. Chung, MD
	Dr. Colleen Kershaw, MD This Doctor is OpenDoctor Recommended.
	Dr. John Z. Ayanian, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Justin P. Annes, MD This Doctor is OpenDoctor Recommended.
	Dr. Shweta R. Motiwala, MD
	Dr. Ivana Nikolic, MD This Doctor is OpenDoctor Recommended.
	Dr. Barbara C. Holbert, MD This Doctor is OpenDoctor Recommended.
	Dr. Pamela J. Cattel, MD This Doctor is OpenDoctor Recommended.
	Dr. Powen Tu, MD
	Dr. Diane E. Rich, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog